A Clinical Study of Surufatinib Combined With Chemotherapy as Neoadjuvant Treatment in Osteosarcoma
Clinical trial NCT05926492 · UNKNOWN
Trial details
- NCT number
- NCT05926492
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-09
- Primary completion
- 2025-07-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.